Eli Lilly & Co. LLY
$1410.99
-0.46%
at last close
Market Cap$1.26 trillion
P/E Ratio—
Div Yield0.49%
Volume3.73M
52-Week Range
$716.08$1449.68
Analyst Ratings
- Consensus
- Buy — 21 Buy · 1 Hold · 1 Sell (23 analysts)
- Avg. Price Target
- $1400.30 (-0.8% downside)
Key Stats
- Today's Range
- $1382.02 – $1421.99
- 50-Day Range
- $1113.29 – $1449.68
- 52-Week Range
- $716.08 – $1449.68
- Volume
- 3.73 million shs
- Average Volume
- 2.49 million shs
- Market Cap
- $1.26 trillion
- P/E Ratio
- —
- Dividend Yield
- 0.49%
Dividend
- Dividend Yield
- 0.49%
- Annual Dividend
- $6.92
- Payout Ratio
- —
- Ex-Dividend Date
- 2026-11-13
Short Interest
- Short Interest
- 1.29%
- Days to Cover
- 5.12
About Eli Lilly & Co.
Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio and Jaypirca for cancer; Mounjaro, Zepbound, Foundayo, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.
Related Stocks
Compare head-to-head: LLY vs JNJ·LLY vs ABBV·LLY vs ABT·LLY vs PFE
Price and fundamental data are delayed and provided for informational purposes only. Not investment advice. See our disclaimer.